LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Hye Jeong | - |
dc.contributor.author | Lee, Jung Ok | - |
dc.contributor.author | Lee, Yong Woo | - |
dc.contributor.author | Kim, Shin Ae | - |
dc.contributor.author | Seo, Il Hyeok | - |
dc.contributor.author | Han, Jeong Ah | - |
dc.contributor.author | Kang, Min Ju | - |
dc.contributor.author | Kim, Su Jin | - |
dc.contributor.author | Cho, Yun-Ho | - |
dc.contributor.author | Park, Joong-Jean | - |
dc.contributor.author | Choi, Jong-Il | - |
dc.contributor.author | Park, Sun Hwa | - |
dc.contributor.author | Kim, Hyeon Soo | - |
dc.date.accessioned | 2021-09-01T14:46:02Z | - |
dc.date.available | 2021-09-01T14:46:02Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2019-06 | - |
dc.identifier.issn | 1461-1457 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/65347 | - |
dc.description.abstract | Background: Leukemia inhibitory factor, a novel myokine, is known to be associated with neural function, but the underlying molecular mechanism remains unclear. Methods: HT-22 mouse hippocampal cells, primary hippocampal cells, and Drosophila Alzheimer's disease model were used to determine the effect of leukemia inhibitory factor on neurons. Immunoblot analysis and immunofluorescence method were used to analyze biological mechanism. Results: Leukemia inhibitory factor increased Akt phosphorylation in a phosphoinositide-3-kinase-dependent manner in hippocampal cells. Leukemia inhibitory factor also increased the phosphorylation of the mammalian target of rapamycin and the downstream S6K. Leukemia inhibitory factor stimulated the phosphorylation of signal transducer and activator of transcription via extracellular signal-regulated kinases. Leukemia inhibitory factor increased c-fos expression through both Akt and extracellular signal-regulated kinases. Leukemia inhibitory factor blocked amyloid beta-induced neural viability suppression and inhibited amyloid beta-induced glucose uptake impairment through the block of amyloid beta-mediated insulin receptor downregulation. Leukemia inhibitory factor blocked amyloid beta-mediated induction of the autophagy marker, microtubule-associated protein 1A/1B-light chain 3. Additionally, in primary prepared hippocampal cells, leukemia inhibitory factor stimulated Akt and extracellular signal-regulated kinase, demonstrating that leukemia inhibitory factor has physiological relevance in vivo. Suppression of the autophagy marker, light chain 3II, by leukemia inhibitory factor was observed in a Drosophila model of Alzheimer's disease. Conclusions: These results demonstrate that leukemia inhibitory factor protects against amyloid beta-induced neurotoxicity via Akt/extracellular signal-regulated kinase-mediated c-fos induction, and thus suggest that leukemia inhibitory factor is a potential drug for Alzheimer's disease. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | OXFORD UNIV PRESS | - |
dc.subject | LEUKEMIA INHIBITORY FACTOR | - |
dc.subject | PHYSICAL-ACTIVITY | - |
dc.subject | C-FOS | - |
dc.subject | RECEPTOR-BETA | - |
dc.subject | GROWTH-FACTOR | - |
dc.subject | ALZHEIMERS | - |
dc.subject | EXPRESSION | - |
dc.subject | EXERCISE | - |
dc.subject | MECHANISMS | - |
dc.subject | DISEASE | - |
dc.title | LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Hye Jeong | - |
dc.contributor.affiliatedAuthor | Park, Joong-Jean | - |
dc.contributor.affiliatedAuthor | Choi, Jong-Il | - |
dc.contributor.affiliatedAuthor | Kim, Hyeon Soo | - |
dc.identifier.doi | 10.1093/ijnp/pyz016 | - |
dc.identifier.scopusid | 2-s2.0-85067087193 | - |
dc.identifier.wosid | 000499132200005 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, v.22, no.6, pp.402 - 414 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | - |
dc.citation.title | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | - |
dc.citation.volume | 22 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 402 | - |
dc.citation.endPage | 414 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | LEUKEMIA INHIBITORY FACTOR | - |
dc.subject.keywordPlus | PHYSICAL-ACTIVITY | - |
dc.subject.keywordPlus | C-FOS | - |
dc.subject.keywordPlus | RECEPTOR-BETA | - |
dc.subject.keywordPlus | GROWTH-FACTOR | - |
dc.subject.keywordPlus | ALZHEIMERS | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | EXERCISE | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | DISEASE | - |
dc.subject.keywordAuthor | LIF | - |
dc.subject.keywordAuthor | Akt | - |
dc.subject.keywordAuthor | autophagy | - |
dc.subject.keywordAuthor | mTOR | - |
dc.subject.keywordAuthor | myokine | - |
dc.subject.keywordAuthor | Alzheimer&apos | - |
dc.subject.keywordAuthor | s disease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.